COVID-19 Vaccine Corporation - Latest News [Page 1]

Delta, Omicron… This Is Just The Beginning Of COVID-19 Variants To Hit New Zealand

Monday, 24 January 2022, 9:05 pm | COVID-19 Vaccine Corporation

AUCKLAND: COVID-19 Vaccine Corporation (CVC), made up of New Zealand’s most experienced group of vaccine producers, is warning people not to take Omicron lightly. There have been numerous media reports suggesting the latest strain of the COVID-19 virus ... More >>

New Zealand’s COVID-19 Vaccine Corporation Partners With Swiss Vaccine Formulation Institute

Saturday, 10 July 2021, 12:51 pm | COVID-19 Vaccine Corporation

New Zealand most experienced vaccine researcher COVID-19 Vaccine Corporation (CVC) has signed a collaboration agreement with not-for-profit Vaccine Formulation Institute (VFI) in Switzerland. CVC began its vaccine production efforts in 2020 and is continuing ... More >>

Local Vaccine Producer Covid-19 Vaccine Corporation Secures More Funding For Its Research

Wednesday, 31 March 2021, 6:11 am | COVID-19 Vaccine Corporation

Callaghan Innovation, New Zealand’s innovation agency, has granted the country’s most experienced group of vaccine producers Covid-19 Vaccine Corporation (CVC) up to $395,274.82 towards their efforts to produce a unique New Zealand’s Covid-19 ... More >>

COVID-19 Vaccine Corporation Partners With The University Of Queensland

Tuesday, 23 February 2021, 1:10 pm | COVID-19 Vaccine Corporation

AUCKLAND: COVID-19 Vaccine Corporation (CVC) has joined forces with the University of Queensland in its vaccine production efforts. After halting development of its spike protein based candidate in December, CVC continues to progress development ... More >>

Kiwi COVID 19 Vaccine Developer In Biobead Tech Collaboration

Thursday, 13 August 2020, 4:40 pm | COVID-19 Vaccine Corporation

COVID-19 Vaccine Corporation (CVC) , New Zealand’s COVID-19 vaccine development company, is collaborating with Dr Iain Hay, senior lecturer in Biological Sciences at the University of Auckland and his group. The university’s commercialisation ... More >>